Role of steatotic liver disease in prediction and prevention of cardiometabolic diseases

被引：12
|
作者：
Stefan, Norbert [1 ,2 ]
Lonardo, Amedeo [3 ]
Targher, Giovanni [4 ,5 ]
机构：
[1] Univ Tubingen, Dept Internal Med 4, Div Endocrinol Diabetol & Nephrol, Tubingen, Germany
[2] Helmholtz Ctr Munich, Inst Diabet Res & Metab Dis IDM, Tubingen, Germany
[3] Azienda Osped Univ Modena, Dept Internal Med, Modena, Italy
[4] Univ Verona, Dept Med, Sect Endocrinol Diabet & Metab, Verona, Italy
[5] IRCCS Sacro Cuore Don Calabria Hosp, Metab Dis Res Unit, Verona, Italy
来源：
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY | 2024年 / 21卷 / 03期
关键词：
D O I：
10.1038/s41575-023-00880-2
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Steatotic liver disease has emerged as an important risk factor for cardiovascular disease, type 2 diabetes mellitus and chronic kidney disease. Successful treatment of steatotic liver disease might also be effective in preventing these cardiometabolic diseases.
引用
收藏
页码：136 / 137
页数：2
相关论文
共 50 条
  • [41] Implications of the new nomenclature of steatotic liver disease and definition of metabolic dysfunction-associated steatotic liver disease
    Loomba, Rohit
    Wong, Vincent Wai-Sun
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 (02) : 150 - 156
  • [42] The Role of Extrahepatic Features on the Development and Management of Hepatocellular Carcinoma in Steatotic Liver Disease
    Zampaglione, Lucia
    Ferrari, Jacopo
    Violi, Naik Vietti
    Goossens, Nicolas
    DISCOVERY MEDICINE, 2024, 36 (185) : 1127 - 1138
  • [43] Role of the Gut Microbiome in Metabolic Dysfunction-Associated Steatotic Liver Disease
    Maher, Salim
    Rajapakse, Jayashi
    El-Omar, Emad
    Zekry, Amany
    SEMINARS IN LIVER DISEASE, 2024, 44 (04) : 457 - 473
  • [44] Inflammation in Steatotic Liver Diseases: Pathogenesis and Therapeutic Targets
    Qian, Shengying
    Wang, Xiaolin
    Chen, Yingfen
    Zai, Qiuhong
    He, Yong
    SEMINARS IN LIVER DISEASE, 2024, 44 (03) : 319 - 332
  • [45] Treatment of liver cirrhosis in the era of steatotic liver disease
    Shimizu, Masahito
    HEPATOLOGY RESEARCH, 2024, 54 (08) : 727 - 728
  • [46] Mechanisms of Lipid Droplet Accumulation in Steatotic Liver Diseases
    Dempsey, Joseph L.
    Ioannou, George N.
    Carr, Rotonya M.
    SEMINARS IN LIVER DISEASE, 2023, 43 (04) : 367 - 382
  • [47] A Novel Point-of-Care Prediction Model for Steatotic Liver Disease: Expected Role of Mass Screening in the Global Obesity Crisis
    Park, Jeayeon
    Chung, Goh Eun
    Chang, Yoosoo
    Kim, So Eun
    Sohn, Won
    Ryu, Seungho
    Ko, Yunmi
    Park, Youngsu
    Hur, Moon Haeng
    Lee, Yun Bin
    Cho, Eun Ju
    Lee, Jeong-Hoon
    Yu, Su Jong
    Yoon, Jung-Hwan
    Kim, Yoon Jun
    GUT AND LIVER, 2025, 19 (01) : 126 - 135
  • [48] The association between alcohol consumption and cardiometabolic factors and liver fibrosis in metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction and alcohol-associated liver disease
    Sogabe, Masahiro
    Okahisa, Toshiya
    Kagawa, Miwako
    Kashihara, Takanori
    Shinomiya, Ryo
    Miyake, Takanori
    Kawaguchi, Tomoyuki
    Yokoyama, Reiko
    Kagemoto, Kaizo
    Kida, Yoshifumi
    Okada, Yasuyuki
    Tomonari, Tetsu
    Kawano, Yutaka
    Sato, Yasushi
    Nakasono, Masahiko
    Takayama, Tetsuji
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 60 (11-12) : 1587 - 1598
  • [49] Role of Vitamin D in Cardiometabolic Diseases
    Wang, Chaoxun
    JOURNAL OF DIABETES RESEARCH, 2013, 2013
  • [50] Metabolic dysfunction-associated steatotic liver disease and risk of four intrahepatic and extrahepatic diseases
    Xiao, Yiyuan
    Xu, Sihua
    Hu, Wenyan
    Huang, Jiapeng
    Jiang, Deke
    Na, Rong
    Yin, Zhaoqing
    Zhang, Jingjing
    Chen, Haitao
    ANNALS OF HEPATOLOGY, 2025, 30 (01)
12345